Other genes that exhibited prognostic potential in HCC include RNF34 (P = 6.72 × 10−8), SKA1 (P = 9.60 × 10−8), SLC16A3/MCT4 (P = 1.19 × 10−7), SLC25A19 (P = 1.21 × 10−7), BRD9 (P = 5.88 × 10−7), and CIT (P = 3.61 × 10−6) [40–45]. This evidence concerns the gene SLC16A3 and hepatocellular carcinoma.